Vor Biopharma

Price & Volume

Stats

52W Range	$2.62-$65.80
Market Cap	$174.1M
Shares Short	294,571

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$387.84

News

Yahoo Finance • 16 days ago

Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Yahoo Finance • 19 days ago

Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock

Yahoo Finance • 21 days ago

Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China

Yahoo Finance • last month

Telitacicept Demonstrates Sustained Efficacy and Favorable Safety Profile in 48-Week China Phase 3 Open-Label Extension Generalized Myasthenia Gravis Data

About

CEO	Dr. Jean-Paul Kress M.D.
CFO	Mr. Sandesh Mahatme L.L.M.
Address	100 Cambridgepark Drive, Cambridge, MA, United States, 02140
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	154